{"disease":{"id":"pulmonary-aspergillosis-invasive","name":"pulmonary aspergillosis invasive"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05671328","title":"Incidence of Invasive Pulmonary Aspergillosis in Ventilator-associated Pneumonia","phase":"","overall_status":"COMPLETED","enrollment_count":263,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT03059992","title":"Study to Evaluate the Efficacy and Safety of Ibrexafungerp in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":233,"lead_sponsor_name":"Scynexis, Inc.","has_results":true},{"nct_id":"NCT05569824","title":"LFD of Aspergillus Antigen in Paediatrics","phase":"","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"St George's University Hospitals NHS Foundation Trust","has_results":false},{"nct_id":"NCT02856178","title":"Study on Safety and Pharmacokinetics of Intravenous F901318 for Fungal Prophylaxis in AML Patients","phase":"PHASE1, PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"F2G Biotech GmbH","has_results":false},{"nct_id":"NCT00923832","title":"Early Molecular Detection for the Improved Diagnosis of Invasive Pulmonary Aspergillosis and Invasive Pulmonary Zygomycosis","phase":"","overall_status":"COMPLETED","enrollment_count":null,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false}],"total":5},"guidelines":[],"source":"Drug Landscape verified database"}